title: Limitations to basal and insulin-stimulated skeletal muscle glucose uptake in the high-fat-fed rat.
abstract: Rats fed a high-fat diet display blunted insulin-stimulated skeletal muscle glucose uptake. It is not clear whether this is due solely to a defect in glucose transport, or if glucose delivery and phosphorylation are also impaired. To determine this, rats were fed standard chow (control rats) or a high-fat diet (HF rats) for 4 wk. Experiments were then performed on conscious rats under basal conditions or during hyperinsulinemic euglycemic clamps. Rats received primed constant infusions of 3-O-methyl-[(3)H]glucose (3-O-MG) and [1-(14)C]mannitol. Total muscle glucose concentration and the steady-state ratio of intracellular to extracellular 3-O-MG concentration [which distributes based on the transsarcolemmal glucose gradient (TSGG)] were used to calculate glucose concentrations at the inner and outer sarcolemmal surfaces ([G](im) and [G](om), respectively) in soleus. Total muscle glucose was also measured in two fast-twitch muscles. Muscle glucose uptake was markedly decreased in HF rats. In control rats, hyperinsulinemia resulted in a decrease in soleus TSGG compared with basal, due to increased [G](im). In HF rats during hyperinsulinemia, [G](im) also exceeded zero. Hyperinsulinemia also decreased muscle glucose in HF rats, implicating impaired glucose delivery. In conclusion, defects in extracellular and intracellular components of muscle glucose uptake are of major functional significance in this model of insulin resistance.
authors.affiliation: Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
authors.forename: A E
authors.initials: AE
authors.lastname: Halseth
authors.forename: D P
authors.initials: DP
authors.lastname: Bracy
authors.forename: D H
authors.initials: DH
authors.lastname: Wasserman
mesh_terms: D019325:3-O-Methylglucose / Q000008:administration & dosage / Q000378:metabolism; D000818:Animals; D001158:Arteries; D001692:Biological Transport / Q000187:drug effects; D001786:Blood Glucose / Q000032:analysis; D001834:Body Water; D002250:Carbon Radioisotopes; D004041:Dietary Fats / Q000008:administration & dosage*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005947:Glucose / Q000032:analysis / Q000378:metabolism*; D006946:Hyperinsulinism / Q000378:metabolism; D007328:Insulin / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D008353:Mannitol / Q000008:administration & dosage / Q000378:metabolism; D018482:Muscle, Skeletal / Q000737:chemistry / Q000187:drug effects* / Q000378:metabolism*; D010766:Phosphorylation; D051381:Rats; D017207:Rats, Sprague-Dawley; D014316:Tritium
chemical_list: D001786:Blood Glucose; D002250:Carbon Radioisotopes; D004041:Dietary Fats; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D014316:Tritium; D019325:3-O-Methylglucose; D008353:Mannitol; D005947:Glucose